Twelve hours of sustained ventricular fibrillation supported by a continuous-flow left ventricular assist device

Pacing Clin Electrophysiol. 2012 May;35(5):e144-8. doi: 10.1111/j.1540-8159.2011.03159.x. Epub 2011 Jun 16.

Abstract

Left ventricular assist device (LVAD) therapy improves survival and quality of life by mechanically unloading the left ventricle and maintaining hemodynamics in patients with end-stage heart failure. LVADs can also be lifesaving by maintaining hemodynamics during ventricular arrhythmia. Continuous-flow LVADs have become the preferred LVAD technology. As presented here, a continuous-flow LVAD successfully provided hemodynamic support to a patient in sustained ventricular fibrillation for over 12 hours when the internal defibrillator was unable to terminate the arrhythmia. This case demonstrates that continuous-flow LVADs can be lifesaving in the setting of otherwise certain hemodynamic collapse from sustained ventricular fibrillation.

Publication types

  • Case Reports
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Heart-Assist Devices*
  • Humans
  • Male
  • Middle Aged
  • Recurrence
  • Treatment Outcome
  • Ventricular Dysfunction, Left / etiology*
  • Ventricular Dysfunction, Left / prevention & control*
  • Ventricular Fibrillation / complications*
  • Ventricular Fibrillation / rehabilitation*